ÂÜÀòÂÒÂ×

Patty Limphong is the Chief Executive Officer and Founder of SoCal Biosciences. With over 15 years of experience, Dr. Limphong has an exceptional background and technical foundation in oligonucleotides, large molecules, small molecules, cell-based assays, and analytical/bioanalytical assay development. Prior to SoCal Biosciences, Dr. Limphong was a Director at Arcturus Therapeutics where she co-developed and established the mRNA and siRNA platform, resulting in over 6 patents granted and pending. At Arcturus, Dr. Limphong formed and grew two well-recognized departments: mRNA Production and Process Development team and a Bioanalytical team where she led the development of several analytical and bioanalytical assays to support pipeline growth and progression. Dr. Limphong also has expertise in stem cell and cell biology. She had the opportunity to learn stem cell and iPSC techniques at the Gladstone Institute, UCSF under Dr. Deepak Srivastava and Dr. Shinya Yamanaka. She used her knowledge and expertise to build the stem cell core facility at the University of Utah Hospital and at the John Hopkins Hospital where she supported scientific research and trained scientists, post-doctoral researchers, and students. Dr. Limphong is highly experienced with assay development, method qualification, and method transfer, and leading the execution of assays at CMOs and CROs for non-clinical and clinical studies; accountable for over 20 non-clinical and clinical studies. She has authored and prepared numerous bioanalytical and pharmacokinetic (PK) sections of regulatory submissions (i.e., IND, CTA, IB, jNDA) to enable clinical trials for vaccines and therapeutic programs. She is the author of over 20 peer review publications and books and serves as a consultant for several companies in the biotech industry. Patty Limphong earned her Ph.D. in Chemistry and Biochemistry from Miami University, Oxford, OH.